Company Filing History:
Years Active: 2011-2013
Title: Innovations of Rene Djurup in Vaccine Purification
Introduction
Rene Djurup is a notable inventor based in Gentofte, Denmark. He has made significant contributions to the field of vaccine development, particularly in the purification of vaccinia virus-based vaccines. With a total of 4 patents, Djurup's work is pivotal in enhancing the efficiency and stability of vaccine preparations.
Latest Patents
Djurup's latest patents focus on the purification of vaccinia viruses and recombinant vaccinia virus-based vaccines. The inventions relate to methods that lead to highly pure and stable virus preparations, predominantly containing biologically active viruses. These methods encompass purifying a virus preparation in a sterilized manner, achieving high efficiency and desirable yields in terms of purity, biological activity, and stability. Such advancements are advantageous for industrial production, ensuring that vaccines are both effective and safe for public use.
Career Highlights
Rene Djurup is currently associated with Bavarian Nordic A/S, a company known for its innovative approaches in the biotechnology sector. His work at Bavarian Nordic A/S has allowed him to focus on developing cutting-edge solutions for vaccine production, contributing to the global fight against infectious diseases.
Collaborations
Djurup collaborates with Sara Post Hansen, who is also involved in the research and development of vaccine technologies. Their partnership exemplifies the importance of teamwork in advancing scientific research and innovation.
Conclusion
Rene Djurup's contributions to vaccine purification represent a significant advancement in the field of biotechnology. His innovative methods and collaborative efforts continue to pave the way for more effective vaccine production, ultimately benefiting public health.